Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 3, 2023	4	Statement of changes in beneficial ownership of securities	0001562180-23-002200.pdf 0001562180-23-002200.rtf 0001562180-23-002200.xls View HTML
March 9, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-065311.pdf 0001193125-23-065311.rtf 0001193125-23-065311.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 10, 2023	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001628280-23-007539.pdf 0001628280-23-007539.rtf 0001628280-23-007539.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 17, 2023	DEFR14A	DEFR14A	0001193125-23-073252.pdf 0001193125-23-073252.rtf 0001193125-23-073252.xls View HTML
March 24, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-078620.pdf 0001193125-23-078620.rtf View HTML
March 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-080505.pdf 0001193125-23-080505.rtf View HTML
March 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-080560.pdf 0001193125-23-080560.rtf View HTML
March 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-080563.pdf 0001193125-23-080563.rtf View HTML
March 31, 2023	DEFA14A	Additional proxy soliciting materials - definitive	0001193125-23-088046.pdf 0001193125-23-088046.rtf View HTML
April 11, 2023	8-K	Report of unscheduled material events or corporate event	0001193125-23-097482.pdf 0001193125-23-097482.rtf 0001193125-23-097482.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax